Bortezomib Related Products
Bortezomib is a medication used to treat multiple myeloma, a type of blood cancer.It is available as a generic medication.
Vsquare is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Bortezomib, pharmacopeial and non-pharmacopeial Bortezomib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Bortezomib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Bortezomib-related products are thoroughly characterized. Bortezomib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.
Pharmaceutical Reference Standards
(S,R)-Bortezomib Hydroxyisopentyl Amide Analog
| CAT No | : VV-B002029 |
| CAS No | : 289472-78-2 |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
Bortezomib Amino R Isomer (TFA salt)
| CAT No | : VV-B002002 |
| CAS No | : 179324-87-9 |
| Mol.F. | : C15H28BNO2 : C2HF3O2 |
| Mol.Wt. | : 265.2 : 114.0 |
| Rel. CAS No | : 179324-86-8 (Free base) |
Bortezomib D-Mannitol Ester
| CAT No | : VV-B002003 |
| CAS No | : 444576-08-3 |
| Mol.F. | : C25H35BN4O8 |
| Mol.Wt. | : 530.4 |
Bortezomib Hydroxy Ketone Analog
| CAT No | : VV-B002005 |
| CAS No | : 2379402-85-2 |
| Mol.F. | : C19H22N4O4 |
| Mol.Wt. | : 370.4 |
Bortezomib Impurity (R,R-Isomer)
| CAT No | : VV-B002006 |
| CAS No | : 1132709-15-9 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
Bortezomib Impurity (R,S-Isomer)
| CAT No | : VV-B002007 |
| CAS No | : 1132709-16-0 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
Bortezomib Impurity (S,S-Isomer)
| CAT No | : VV-B002008 |
| CAS No | : 1132709-14-8 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
Bortezomib Impurity 14
| CAT No | : VV-B002010 |
| CAS No | : 205393-22-2 |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
| Rel. CAS No | : 1187479-73-7 (HCl salt) |
Bortezomib Impurity 15
| CAT No | : VV-B002011 |
| CAS No | : 1259365-04-2 |
| Mol.F. | : C11H24BNO2 |
| Mol.Wt. | : 213.1 |
| Rel. CAS No | : 1259300-03-2 (HCl salt) |
Bortezomib Impurity 2 (Mixture of (1S,2R)-Isomer and (1R,2R)-Isomer)
| CAT No | : VV-B002015 |
| CAS No | : 2747958-64-9 |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
Bortezomib Impurity 2 (RR-Isomer)
| CAT No | : VV-B002016 |
| CAS No | : NA |
| Mol.F. | : C19H24N4O3 |
| Mol.Wt. | : 356.4 |
Bortezomib Impurity 21
| CAT No | : VV-B002018 |
| CAS No | : 94242-79-2 |
| Mol.F. | : C20H42BNO2Si2 |
| Mol.Wt. | : 395.6 |
Bortezomib Impurity 28
| CAT No | : VV-B002023 |
| CAS No | : 18942-49-9 |
| Mol.F. | : C14H19NO4 |
| Mol.Wt. | : 265.3 |
| Rel. CAS No | : 169131-65-1 (HCl salt) ; 1013327-78-0 (Na salt) |
Bortezomib Impurity 29
| CAT No | : VV-B002024 |
| CAS No | : 89-01-0 |
| Mol.F. | : C6H4N2O4 |
| Mol.Wt. | : 168.1 |
| Rel. CAS No | : 93778-20-2 (Na salt) ; 859063-48-2 (K salt) |
Bortezomib Impurity 3
| CAT No | : VV-B002025 |
| CAS No | : NA |
| Mol.F. | : C14H14N4O2 : HCl |
| Mol.Wt. | : 270.3 : 36.5 |
| Rel. CAS No | : 2748159-75-1 (free base) |
Bortezomib Impurity 32
| CAT No | : VV-B002028 |
| CAS No | : 2363753-29-9 |
| Mol.F. | : C15H28BNO2 : C2HF3O2 |
| Mol.Wt. | : 265.2 : 114.0 |
| Rel. CAS No | : 1173239-14-9 (Free base) |
Bortezomib Impurity 33
| CAT No | : VV-B002030 |
| CAS No | : 948294-96-0 |
| Mol.F. | : C14H23BN2O3 |
| Mol.Wt. | : 278.2 |
| Rel. CAS No | : 2413962-44-2 (HCl salt) |
Bortezomib Impurity 36
| CAT No | : VV-B002032 |
| CAS No | : 114457-94-2 |
| Mol.F. | : C14H13N3O3 |
| Mol.Wt. | : 271.3 |
| Rel. CAS No | : 1093959-75-1 (Na salt) ; 1093959-76-2 (K salt) |
Bortezomib Impurity 37
| CAT No | : VV-B002033 |
| CAS No | : 1798895-16-5 |
| Mol.F. | : C15H15N3O3 |
| Mol.Wt. | : 285.3 |
Bortezomib Impurity 41
| CAT No | : VV-B002038 |
| CAS No | : 514820-48-5 |
| Mol.F. | : C21H44BNO2Si2 |
| Mol.Wt. | : 409.6 |
Bortezomib Impurity 42
| CAT No | : VV-B002039 |
| CAS No | : 477254-69-6 |
| Mol.F. | : C15H28BNO2 : C2HF3O2 |
| Mol.Wt. | : 265.2 : 114.0 |
| Rel. CAS No | : 477254-68-5 (Free base) |
Bortezomib Impurity 45
| CAT No | : VV-B002042 |
| CAS No | : 1255646-95-7 |
| Mol.F. | : C17H18N2O3 |
| Mol.Wt. | : 298.3 |
Bortezomib Impurity 46
| CAT No | : VV-B002043 |
| CAS No | : 2577-40-4 |
| Mol.F. | : C18H20N2O3 |
| Mol.Wt. | : 312.4 |
| Rel. CAS No | : 68800-30-6 (HCl salt) ; 1087344-12-4 (HBr salt) ; 1841445-65-5 (Na salt) ; 1307315-69-0 (TFA salt) |
Bortezomib Impurity 47
| CAT No | : VV-B002044 |
| CAS No | : 1194235-14-7 |
| Mol.F. | : C23H22N4O4 |
| Mol.Wt. | : 418.5 |
Bortezomib Impurity 53
| CAT No | : VV-B002047 |
| CAS No | : 2364553-64-8 |
| Mol.F. | : C14H13N3O3 |
| Mol.Wt. | : 271.3 |
Bortezomib Impurity 54
| CAT No | : VV-B002048 |
| CAS No | : 110755-29-8 |
| Mol.F. | : C14H22N2O |
| Mol.Wt. | : 234.3 |
| Rel. CAS No | : 292061-26-8 (HCl salt) |
Bortezomib Impurity 71
| CAT No | : VV-B002053 |
| CAS No | : 1579304-37-2 |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
Bortezomib Impurity 78
| CAT No | : VV-B002059 |
| CAS No | : 1135491-84-7 |
| Mol.F. | : C21H44BNO2Si2 |
| Mol.Wt. | : 409.6 |
Bortezomib Impurity 80
| CAT No | : VV-B002062 |
| CAS No | : 2748159-75-1 |
| Mol.F. | : C14H14N4O2 |
| Mol.Wt. | : 270.3 |
Bortezomib Impurity 9
| CAT No | : VV-B002064 |
| CAS No | : 1194235-41-0 |
| Mol.F. | : C28H34BN5O5 |
| Mol.Wt. | : 531.4 |
Bortezomib Impurity C (Mixture of Isomers)
| CAT No | : VV-B002067 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.3 |
Bortezomib Intermediate(R,S)
| CAT No | : VV-B002073 |
| CAS No | : 2363753-37-9 |
| Mol.F. | : C14H25BO2 |
| Mol.Wt. | : 236.2 |
Bortezomib Intermediate(S,R)
| CAT No | : VV-B002074 |
| CAS No | : 84110-34-9 |
| Mol.F. | : C14H25BO2 |
| Mol.Wt. | : 236.2 |
Bortezomib Isoamyl Impurity
| CAT No | : VV-B002075 |
| CAS No | : 1375004-39-9 |
| Mol.F. | : C29H39BN4O4 |
| Mol.Wt. | : 518.5 |
Bortezomib R and S Hydroperoxide
| CAT No | : VV-B002076 |
| CAS No | : NA |
| Mol.F. | : 2(C19H24N4O4) |
| Mol.Wt. | : 2(372.4) |
Bortezomib R-Hydroperoxide
| CAT No | : VV-B002077 |
| CAS No | : 886979-78-8 |
| Mol.F. | : C19H24N4O4 |
| Mol.Wt. | : 372.4 |
Bortezomib S-Hydroperoxide
| CAT No | : VV-B002083 |
| CAS No | : 886979-81-3 |
| Mol.F. | : C19H24N4O4 |
| Mol.Wt. | : 372.4 |
Bortezomib Stereo Isomers Mixture
| CAT No | : VV-B002084 |
| CAS No | : NA |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
Desisobutyl-n-butyl Bortezomib
| CAT No | : VV-B002086 |
| CAS No | : 1104011-35-9 |
| Mol.F. | : C19H25BN4O4 |
| Mol.Wt. | : 384.2 |
N-(2-pyraziny| carbony|)-D-Phenylalanine
| CAT No | : VV-B002087 |
| CAS No | : 1608986-16-8 |
| Mol.F. | : C14H13N3O3 |
| Mol.Wt. | : 271.3 |
